SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #1,483CAS 2区Top JournalReview JournalHybrid

Critical Reviews in Oncology Hematology

Abbreviation (ISO):CRIT REV ONCOL HEMAT
Country: United States•WoS SCIE Quartile: Q1•Scopus SJR: 1.977•SCImago Rank: #1,483•Identifier (ISSN):1040-8428(Print)/1879-0461(Online)•Articles / Year: 250•Estimated Publication Fee (APC): $3,660 USD
Clarivate IF (2026)Q1
6.2
↑ +0.6

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
111

111 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate1.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
250articles/year
31.46% Gold OA•0% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 6.2)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.2)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.6)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.5)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.2)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.625)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.312)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.833)
🔵 Computed
20193.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.012)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.495)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology written by experts from around the world. Critical Reviews in Oncology/Hematology is the Official Journal of the European School of Oncology (ESO) and the International Society of Liquid Biopsy.

Topics Covered (Recognized by AI)
Medicine99.7%Biology83.1%Internal medicine82.4%Genetics76.8%Cancer58.4%Pathology54%Oncology46%Surgery43.7%Chemistry37.9%Biochemistry32.7%Immunology30%Chemotherapy23.5%Cancer research23%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #1,483Scopus Q1SCImago Profile
Scopus Coverage:1983-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.977

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
160

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
6.71

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,660 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations4,409
3-Year Documents644
Citable Documents639

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Geriatrics and GerontologyQ1
HematologyQ1
OncologyQ1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
27.3周
Average time to first editorial decision
Online Publication Speed
8.8周
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Elsevier Ireland Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1983
Editorial Address
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
HEMATOLOGY
JCRSCIE
15/103Q1
ONCOLOGY
JCRSCIE
60/333Q1
HEMATOLOGY
JCISCIE
25/103Q1
ONCOLOGY
JCISCIE
117/333Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—410363
20255.64172,594
20245.52803,484
20236.22123,485
20226.6252115,880
20216.3122466,640
20205.8332409,426
20195.0122028,988
20184.4951918,297
2017—20212,957
2016—1979,554
2015—19910,829
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Critical Reviews in Oncology Hematology

WoS Q1
3568201820192020202120222023202420255.60
Annual Impact Factor Metric
2025:5.6

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 1.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 37d766e3-3e76-481e-bacb-8ca6177a43b8
Database Updated: 2026-10-01